Prostaglandin E2 receptor EP1 expression in vulvar cancer

[1] Abramovitz M(2000)The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs Biochim Biophys Acta 1483 285-293

[2] Adam M(2021)Combined COX-2/PPARγ expression as independent negative prognosticator for vulvar cancer patients Diagnostics (basel) 11 491-1841

[3] Boie Y(2013)Prostaglandin E2 receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells Int J Oncol 42 1833-2771

[4] Carrière M(2015)Use of cetuximab in combination with cisplatin and adjuvant pelvic radiation for stage IIIB vulvar carcinoma Case Rep Obstet Gynecol 2015 2764-948

[5] Denis D(2020)Geographic and temporal variations in the incidence of vulvar and vaginal cancers Int J Cancer 147 1410-189

[6] Godbout C(2021)EP4 as a negative prognostic factor in patients with vulvar cancer Cancers (basel) 13 932-519

[7] Lamontagne S(1998)Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia Hum Pathol 29 180-297

[8] Rochette C(1992)Cigarette smoking and the risk of anogenital cancer Am J Epidemiol 135 511-240

[9] Sawyer N(2021)A risk factor analysis of complications after surgery for vulvar cancer Arch Gynecol Obstet 304 289-17223

[10] Tremblay NM(2008)Decreased survival in EGFR gene amplified vulvar carcinoma Gynecol Oncol 111 232-146

[1] Abramovitz M(2000)The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs Biochim Biophys Acta 1483 285-293

[2] Adam M(2021)Combined COX-2/PPARγ expression as independent negative prognosticator for vulvar cancer patients Diagnostics (basel) 11 491-1841

[3] Boie Y(2013)Prostaglandin E2 receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells Int J Oncol 42 1833-2771

[4] Carrière M(2015)Use of cetuximab in combination with cisplatin and adjuvant pelvic radiation for stage IIIB vulvar carcinoma Case Rep Obstet Gynecol 2015 2764-948

[5] Denis D(2020)Geographic and temporal variations in the incidence of vulvar and vaginal cancers Int J Cancer 147 1410-189

[6] Godbout C(2021)EP4 as a negative prognostic factor in patients with vulvar cancer Cancers (basel) 13 932-519

[7] Lamontagne S(1998)Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia Hum Pathol 29 180-297

[8] Rochette C(1992)Cigarette smoking and the risk of anogenital cancer Am J Epidemiol 135 511-240

[9] Sawyer N(2021)A risk factor analysis of complications after surgery for vulvar cancer Arch Gynecol Obstet 304 289-17223

[10] Tremblay NM(2008)Decreased survival in EGFR gene amplified vulvar carcinoma Gynecol Oncol 111 232-146